01/26
Headlines

AbbVie Inc

Market Movers: AbbVie Inc. (NYSE:ABBV), Morgan Stanley (NYSE:MS), Sanmina Corporation (NASDAQ:SANM), Advanced Semiconductor Engineering Inc. (NYSE:ASX), Resource Capital Corp. (NYSE:RSO)

Richard Atkins03 mins

AbbVie Inc. (NYSE:ABBV) rival Gilead makes exclusive deal with CVS for hep C drugs. The deal blocks North Chicago-based AbbVie Inc.’s treatment, called Viekira Pak, which will only be available to patients given approval because of medical exceptions or through a process called prior authorization, according to CVS. Patients already taking Viekira Pak will be…

Read More

Trader’s Buzz: AbbVie Inc. (NYSE:ABBV), Twenty-First Century Fox, Inc. (NASDAQ:FOXA), Brunswick Corporation (NYSE:BC), Cheniere Energy, Inc. (NYSEMKT:LNG), Forward Industries Inc. (NASDAQ:FORD)

Kristen Barton02 mins

On Dec. 23, AbbVie (NYSE:ABBV) will participate in the Goldman Sachs Healthcare CEOs Unscripted Conference on Tuesday, Jan. 6, 2015. Richard A. Gonzalez, chairman and chief executive officer, will take part in a question and answer session at 2:15 p.m. Central time. AbbVie Inc. (NYSE:ABBV) belongs to Healthcare sector. Its net profit margin is 18.90%…

Read More

Top Wall Street Stories: Wells Fargo & Company (NYSE:WFC), AbbVie Inc. (NYSE:ABBV), Sigma-Aldrich Corporation (NASDAQ:SIAL), Sanofi SA (ADR) (NYSE:SNY), Sprint Corporation (NYSE:S)

Kristen Barton03 mins

Wells Fargo & Company (NYSE:WFC)’s Wealth, Brokerage and Retirement (WBR) division today announced the launch of Wells Fargo Investment Institute (WFII). WFII brings together the investment research, strategy, manager research and publications teams from WBR’s four lines of business to create a single group with a goal of providing world-class advice to the company’s financial…

Read More

Stocks Swings: AbbVie Inc. (NYSE:ABBV), Yelp, Inc. (NYSE:YELP), Universal Health Services Inc. (NYSE:UHS), Tompkins Financial Corporation (NYSEMKT:TMP), Walgreen Co. (NYSE:WAG)

Kevin Long02 mins

AbbVie (NYSE:ABBV) said that it presented new results from a Phase 2 study of investigational compound venetoclax (ABT-199/GDC-0199) in patients with acute myelogenous leukemia or AML at the 56th American Society of Hematology Annual Meeting. AbbVie Inc. (NYSE:ABBV) belongs to Healthcare sector. Its net profit margin is 18.90% and weekly performance is 0.74%. On last…

Read More

Don’t Miss: AbbVie Inc. (NYSE:ABBV), Occidental Petroleum Corporation (NYSE:OXY), Quaker Chemical Corporation (NYSE:KWR), Issuer Direct Corporation (NYSEMKT:ISDR), Sirius XM Holdings Inc. (NASDAQ:SIRI)

Jayne Crisman03 mins

AbbVie Inc. (NYSE:ABBV) will present data evaluating three investigational compounds from the company’s oncology pipeline at the upcoming 56th American Society of Hematology Annual Meeting (ASH), December 6-9, in San Francisco. Data will be highlighted in 13 accepted abstracts, including several oral presentations detailing new trial results from the venetoclax program in acute myelogenous leukemia,…

Read More

Today’s Watch List: Micron Technology, Inc. (NASDAQ:MU), AbbVie Inc. (NYSE:ABBV), Sealed Air Corporation (NYSE:SEE), Amkor Technology, Inc. (NASDAQ:AMKR), Wynn Resorts Ltd. (NASDAQ:WYNN)

Kristen Barton03 mins

Micron Technology, Inc. (NASDAQ:MU) and Wave Systems Corp., are expanding their collaboration to include Lenovo and American Megatrends Inc. in developing advanced enterprise-class security offerings to address the escalating concerns of governments and multinational businesses. Micron Technology, Inc. (NASDAQ:MU) in last trading activity decreased -1.01% to close at $32.28. Company weekly performance is 5.59% while…

Read More